InvestorsHub Logo
Followers 1
Posts 80
Boards Moderated 0
Alias Born 10/03/2012

Re: None

Wednesday, 11/26/2014 9:10:47 AM

Wednesday, November 26, 2014 9:10:47 AM

Post# of 12450
IntelGenx Announces Update to Settlement of U.S. Patent Litigation Related to Forfivo XL(R)BY GlobeNewswire
— 8:41 AM ET 11/26/2014
SAINT LAURENT, Quebec, Nov. 26, 2014 (GLOBE NEWSWIRE) -- IntelGenx Corp. (OTCQX:IGXT) ("IntelGenx") today announced that it has settled its Paragraph IV litigation with Wockhardt Bio AG related to IntelGenx (IGXT
Loading...
Loading...


)' Forfivo XL® 450 mg tablets.

Under the terms of the settlement, Wockhardt has been granted the rights, with effect from January 15, 2018, to be the exclusive marketer and distributor of an authorized generic of Forfivo XL® in the U.S.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IGXT News